Treatment With Intent to Generate Endovascular Reperfusion
A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 160 participants.
Also called NCT03474549
- Study
- In this atlas
Overview
- Design
- Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 160 participants
- Sponsor
- Rapid Medical
- Registry
-
NCT03474549
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- United States, Israel
- Registry status
- Completed
Technical summary
Registry record NCT03474549. Allocation not applicable; no masking; primary purpose treatment. Start 2018-05-09 (actual); primary completion 2020-04-15 (actual). Results posted on 2024-05-08.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Treatment With Intent to Generate Endovascular Reperfusion
- Acronym
- TIGER
- Condition
- Ischemic Stroke
- Intervention (Device)
- Tigertriever revascularization device
- Lead sponsor
- Rapid Medical
Record details
- Record id
cardio:ct-nct03474549- Content hash
343959a94da3771396031acae861bc8544f8be532df322be034fc835259a73eb